Tuesday, December 05, 2023


CDC Study of Young Children: COVID-19 mRNA Vaccines Bomb, Fail WHO Threshold--Agency Still Promotes Universal Immunization

The Centers for Disease Control and Prevention (CDC) sponsored the latest Morbidity and Mortality Weekly Report (MMWR) focusing on the epidemiology of COVID-19 mRNA vaccine effectiveness concerning young children ranging in age from 6 months to 4 years. tracking vaccine effectiveness from July 2022, to September 2023.

Represented by epidemiologist and corresponding author Heidi Moline, M.D., Ph.D., a large study team acknowledges first and foremost, that “SARS-CoV-2 infection in young children is often mild or asymptomatic; however, some children are at risk for severe disease.” While agencies such as the CDC have promoted universal vaccination for children aged 6 months and up regardless, data as to the protective effectiveness of the mRNA vaccines developed as countermeasures by Pfizer-BioNTech and Moderna have been limited.

The results here, while touted by the authors as reinforcing the universal vaccination position of the CDC, fail a standard World Health Organization threshold for vaccine effectiveness. In fact, Moderna’s vaccine effectiveness in preventing ER or hospitalization equals 29% for two-dose mRNA primary series. This is not preventing infection, but more severe outcomes.

To be approved, vaccines are required to have a high efficacy rate of 50% or above according to the World Health Organization (WHO). After approval, they continue to be monitored for ongoing safety and effectiveness. See link to the WHO.

In this CDC-sponsored study, the investigators use data from a prospective population-based surveillance system called the New Vaccine Surveillance Network.

Tapping into collecting, categorizing and analyzing this data led to estimates of vaccine effectiveness using a test-negative, case-control design. Including 7,434 children included, 5% received a positive SARS-CoV-2 test result, and 95% received a negative test result; 86% were unvaccinated, 4% had received 1 dose of any vaccine product, and 10% had received ≥2 doses.

According to this observational class of study when comparing unvaccinated children with those children receiving ≥2 COVID-19 mRNA vaccine doses the authors report a 40% effective (95% CI = 8%–60%) rate in preventing ED visits and hospitalization. The authors exclude any investigation into vaccine safety, suggesting a form of bias, as a true risk-benefit analysis would need such information.

What is the New Vaccine Surveillance Network (NVSN)?

NVSN conducts population-based, prospective surveillance for acute respiratory illness (ARI) in children at seven pediatric medical centers. The centers include Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Children’s Mercy Hospital, Kansas City, Missouri; Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio; Golisano Children’s Hospital, Rochester, New York; Seattle Children’s Hospital, Seattle, Washington; Texas Children’s Hospital, Houston, Texas; Vanderbilt University Medical Center, Nashville, Tennessee.

How many children received no vaccine?
86%

Were there racial and ethnicity differences in COVID-19 vaccination rates for this vulnerable cohort?

Yes. Compared with White children, Black children were about seven times less likely, and Hispanic/Latino children were approximately three times less likely to have received ≥2 doses of the COVID-19 vaccine.

What was the overall incidence of COVID-19?

Low. Only 5% of children with symptoms turn out to be COVID-19 positive. Also, the authors report co-detections of other respiratory viruses were present in approximately one-third of children who received positive SARS-CoV-2 test results.

So, what was the vaccine's effectiveness in preventing ED visits and hospitalization?

40%. It ranges as low as 8%. Moderna primary series equals 29%.

Do the CDC authors acknowledge the impact of previous exposure/natural immunity in reducing severity of COVID-19 in this young cohort?

Yes.

So, is 40% vaccine effectiveness sufficient for typical standards?

No, especially not 40% against ER or hospitalization. As TrialSite suggests above, WHO recommends 50%. See the link.

What is the rationale for the ongoing recommendation?
According to the authors' own logic, we are not certain. It appears that it's just a generic stance the CDC takes without critically vetting the data. The study authors point out that “Despite low vaccination coverage and the circulation of several Omicron subvariants, COVID-19–associated ED visits and hospitalization among children with ARI enrolled in NVSN were rare, suggesting most children in this age group experience mild illness from these subvariants or have immune protection from previous SARS-CoV-2 exposure (7). These findings indicate that COVID-19 mRNA vaccines are protective and are consistent with other VE estimates for this age group, ranging from 29% for 2-dose Moderna coverage to 43% for 3-dose Pfizer-BioNTech coverage (5); however, low vaccination coverage and low incidence of medically attended COVID-19 limit precision in these VE estimates.”

What are some key limitations?

First and foremost, a vaccine’s efficacy is measured in a controlled clinical trial and is based on how many people who got vaccinated developed the ‘outcome of interest’ (usually disease) compared with how many people who got the placebo (dummy vaccine) developed the same outcome. This class of study does not indicate causation.

Other limitations provided by the authors include

1) seroprevalence of infection-induced SARS-CoV-2 antibodies in children and adolescents has increased over time, which might affect vaccine effectiveness estimates and assessment of severe outcomes, as more children have immunity from previous SARS-CoV-2 infection

2) low vaccination coverage might indicate that vaccinated children are systematically different from unvaccinated children;

3) NVSN data might be subject to enrollment biases that might vary by site, such as number of enrollment days per week and availability of interpreters for non-English speakers;

4) low vaccination coverage and disease incidence limit the precision of the point estimates and were too low to analyze data by time since dose or to stratify by setting or product and

5) Moderna vaccine is administered as a 2-dose primary series whereas Pfizer-BioNTech requires 3 doses, and receipt of ≥2 doses might underestimate the protection afforded by the complete 3-dose Pfizer-BioNTech primary series.

*******************************************************

Skin Disorders Post-COVID-19 Vaccinations

The purpose of the present Op-ed is to identify the scope and number of occurrences of skin and subcutaneous tissue disorders (hereafter abbreviated as skin disorders) that occur following COVID-19 vaccinations.

What are skin disorders? “Skin diseases are conditions that affect your skin. These diseases may cause rashes, inflammation, itchiness or other skin changes. Some skin conditions may be genetic, while lifestyle factors may cause others”. For purposes of this Op-ed, skin disorders encompass Angioedema and urticaria, Cornification and dystrophic skin disorders, Cutaneous neoplasms benign, Epidermal and dermal conditions, Pigmentation disorders, Skin and subcutaneous tissue disorders Not Otherwise Classified, Skin and subcutaneous tissue infections and infestations Not Otherwise Classified, Skin appendage conditions, Skin neoplasms malignant and unspecified, Skin vascular abnormalities.

While cardiovascular disorders, cancers, immune system disorders, and neurological disorders post-COVID-19 vaccination have been studied to a modest extent, skin disorders following COVID-19 vaccination have not been studied to nearly the same extent. This Op-ed will examine a very broad spectrum of skin disorders following COVID-19 vaccinations as reported by VAERS (Vaccine Adverse Events Reporting System). Additionally, the COVID-19 results will be compared to similar results following influenza vaccinations.

METHODOLOGY

Because of the extensive use of the MedDRA (Medical Dictionary for Regulatory Activities) vocabulary in this study, the MedDRA vocabulary will be discussed before the specific methodology is presented. “VAERS uses the MedDRA vocabulary to represent each of the ~18,000 symptoms listed in VAERS. MedDRA consists of five hierarchical levels of symptoms/diseases: System Organ Class (SOC), High-Level Group Terms (HLGT); High-Level Terms (HLT); Preferred Terms (PT); Lower Level Terms (LLT). Only a subset of the bottom level (LLT) is used for the VAERS terminology”. There are 27 SOCS in MedDRA, one of which is Skin and Subcutaneous Tissue Disorders. In the present Op-ed, all the LLT terms that are contained within the Skin and Subcutaneous Tissue Disorders SOC in the full MedDRA database are used to query the VAERS database.

Also, as stated by Medalerts, “the full MedDRA has 87,592 LLT [lowest level terms) symptoms, but VAERS uses only 17,679 (20%).” The MedDRA terms in any category are determined by groups of experts, and are associated with subjectivities and uncertainties that accompany any group decisions.

Now, the specific methodology used to obtain the results will be described. On 23 November 2023, the VAERS database (current as of 27 October 2023), was accessed through CDC Wonder, and all the symptoms were retrieved for COVID-19 vaccines, including those with zero entries. The same type of retrieval was done for influenza vaccines. To obtain the VAERS results for post-COVID-19 vaccination skin disorders, the final list of 6033 MedDRA LLT terms (see Appendix 1 for the specific MedDRA query used to identify skin disorder-related symptoms in VAERS) was intersected with all the ~18,000 VAERS terms to identify VAERS symptoms related to skin disorders post-COVID-19 vaccination (see Appendix 2 for the VAERS COVID-19 results).

Selected VAERS skin disorder results post-COVID-19 vaccinations were also compared to selected VAERS skin disorder results post-influenza vaccinations, using similar numbers of vaccine doses administered. To generate these similar numbers of vaccine doses administered, the influenza VAERS results were retrieved for the period 2019-2023, while the COVID-19 VAERS results were retrieved for the period 2021-2023.

To obtain the VAERS results for post-influenza vaccination skin disorders, the final list of 6033 MedDRA LLT terms was also intersected with all the ~18,000 VAERS terms to identify VAERS symptoms related to skin disorders post-influenza vaccination (see Appendix 3 for the VAERS influenza results).

RESULTS AND DISCUSSION

VAERS Symptoms Related to Skin Disorders Post-COVID-19 Vaccination

The VAERS symptoms related to skin disorders that occurred post-COVID-19 vaccinations are listed in Appendix 2, Table 1. There were 766 symptoms with a non-zero number of events, and a total of 448,517 events. The parallel numbers for post-influenza vaccination are 317 symptoms with a non-zero number of events, and a total of 29,592 events.

To translate from VAERS numbers to real-world numbers, the VAERS numbers (which are strongly under-reported) must be multiplied by an under-reporting factor (URF), to produce real-world numbers. My latest Op-eds use a URF of 66. With that assumption, the total real-world number of skin disorder symptom events post-COVID-19 vaccinations is 448,517 x 66, which equals approximately 29.6 million skin disorder-related events post-COVID-19 vaccinations.

The skin disorders post-COVID-19 vaccinations cover a wide range of symptoms, some of which can be very serious. These latter symptoms include (but are not limited to) Pemphigus vulgaris (52 events), Stevens-Johnson syndrome (43), Toxic epidermal necrolysis (8), Toxic shock syndrome (5), Necrotising fasciitis (16), DRESS syndrome (30) and myriad Skin cancers that are addressed later in this study (168) (link#1; link#2).

Comparison of Skin Disorders Post-COVID-19 Vaccinations and Post-Influenza Vaccinations

Table 1 contains a comparison of selected high/mid-frequency VAERS-related skin disorders terms post-COVID-19 vaccinations and post-Influenza vaccinations. It has been subdivided into five groups. The first group shown in the table (HIGH #COV; ZERO #FLU) contains symptoms that occurred moderately frequently in VAERS post-COVID-19 vaccinations, but did not occur at all in VAERS post-influenza vaccinations.

The second group shown in the table (HIGH #COV; 1 #FLU) contains symptoms that occurred moderately frequently in VAERS post-COVID-19 vaccinations, and once in VAERS post-influenza vaccinations. As in the first group, the most frequent symptom relates to increased skin sensitivity.

The third group shown in the table (HIGH #COV; 2 #FLU) contains symptoms that occurred moderately frequently in VAERS post-COVID-19 vaccinations, and occurred twice in VAERS post-influenza vaccinations.

The fourth group shown in the table (HIGH #COV/#FLU RATIO) contains symptoms that occurred frequently in VAERS post-COVID-19 vaccinations, and occurred much less frequently in VAERS post-influenza vaccinations. As in the first three groups, many types of skin disorders are shown, and there appears to be no central theme.

The fifth group shown in the table (HIGH #COV; HIGH #FLU) contains symptoms that occurred moderately frequently in VAERS post-COVID-19 vaccinations, and occurred moderately less frequently in VAERS post-influenza vaccinations. It is a small group, with symptoms mainly related to injection site issues.

********************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs

***************************************************

Monday, December 04, 2023



US Military Study on Postvaccination Myocarditis Released

A small U.S. military study on postvaccination myocarditis has been quietly released, with authors saying they found no overt or subclinical heart inflammation.

Outside experts said the study did show some concerning signs and that the military researchers failed to explore those signs further.

The U.S. military was one of the first entities in the world to detect myocarditis and a related condition, pericarditis, after COVID-19 vaccination. The military also mandated COVID-19 vaccination for the force.

With those facts in mind, "it is particularly important to understand the prevalence of subclinical myocarditis/pericarditis along with the potential for additional complications," the authors of the new paper said.

The researchers recruited people who received a Pfizer or Moderna modified messenger RNA (mRNA) shot, were between 12 and 40 years of age, and were enrolled in TRICARE, which provides health care for many service members and their family members. The people received a second or subsequent dose of a vaccine between June 2022 and June 2023.

Participants visited investigators within 24 hours of and three to seven days after vaccination. Their symptoms, troponin T levels, and C-reactive protein were measured. Researchers also used electrocardiograms on the patients.

Thirty people ended up being part of the study, with 23 being active-duty military members. Four had a jump in troponin T, an indicator of subclinical heart damage, from 1 to 16 nanograms a liter after vaccination. However, the researchers said none had subclinical myocarditis because they defined subclinical myocarditis as an increase of more than 20 nanograms a liter. A fifth participant reported chest pain and shortness of breath, two possible signs of heart inflammation, but did not have a rise in troponin T.

"This is the first study to report on signs or symptoms of myocarditis/pericarditis collected through active surveillance following administration of mRNA vaccination in a military setting," Dr. Richelle Homo, a pediatric resident at Madigan Army Medical Center and a fellow at Brooke Army Medical Center, and her co-authors wrote.

The authors acknowledged that the study was not large enough to estimate the incidence of myocarditis after vaccination "due to the unpredictable nature of the pandemic and delays in recruitment." By June 2022, many people, including military members, had stopped getting COVID-19 vaccines.

"Nonetheless, the absence of myocarditis/pericarditis in this study offers some reassurance. As mRNA technology continues to advance, a deeper understanding of the incidence and extent of these complications will be necessary to ensure populations are well informed on the risks, benefits and potential need for monitoring following administration," the authors added.

The paper was published by the British Medical Journal.

Experts Weigh In

Several experts who reviewed the paper said the study did not provide any reassurance due to its small population and the definition of subclinical myocarditis.

Rates of clinical myocarditis, or heart inflammation manifesting through symptoms, run around 1 in 3,000 to 6,000 in multiple previous studies.

Defining subclinical myocarditis as troponin raised to a certain level without cardiac MRI cannot rule out the condition, doctors said.

The levels recorded in some of the participants indicate that there was "some damage to the myocardium," according to Dr. Kirk Milhoan, a pediatric cardiologist. He said he'd have liked to see cardiac MRIs performed on those participants.

"Why don't we look further and see what that is, as opposed to saying, 'well, since nothing was over 20, it was just ignored,'" he told The Epoch Times.

Dr. Sanjay Verma, a cardiologist in California, said that elevated troponin, especially at low levels, can have non-vaccine causes and that cardiac imaging helps differentiate between the causes.

Dr. Verma said the study population was important, noting that researchers only included people who received at least their second dose of a vaccine.

"This inclusion criteria by definition would exclude those who may have already had myocarditis after dose 1. Furthermore, 70% of the study population received a fourth dose (i.e., they did not have myocarditis after the first 3). The study therefore is a self selected population of those who didn’t have myocarditis from dose 1-3," Dr. Verma told The Epoch Times in an email.

"Therefore, the study doesn’t prove or disprove anything about the true rate of myocarditis or subclinical myocarditis in all comers who receive dose 1 and 2 of mRNA COVID-10 vaccination."

It's unclear why the researchers chose the 20 nanograms per liter definition. The first study from the military used a definition of 10-fold to 400-fold the upper limits of reference ranges, which, according to the Cleveland Clinic, can be as low as 0.01 nanograms per liter. The first study did require acute chest pain as well, as it looked at clinical myocarditis.

A newer study from Switzerland examining subclinical myocarditis used a minimum of 8.9 nanograms per liter in women and 15.5 nanograms per liter in men, although other requirements were also considered for the final diagnoses.

Dr. Homo did not respond to emailed questions, nor did the Defense Health Agency, which funded the study.

****************************************************

New Report Reveals Biden Admin Pressured YouTube To 'Crack Down On Vaccine Misinformation'

According to a new report, the Biden Administration pressured YouTube to target alleged misinformation relating to the draconian COVID-19 vaccines.

Documents obtained by the House Judiciary Committee show that the Biden White House forced the streaming platform to suppress any negative COVID-19 vaccine information to push more people to get the jab.

In April 2021, President Joe Biden's former Director of Digital Strategy, Robert Flaherty, emailed Google team members to "connect […] about the work you're doing to combat vaccine hesitancy, but also crack down on vaccine misinformation."

More from Fox News Digital:

Flaherty continued, asking for trends surrounding vaccine misinformation on the website while offering government assistance in the form of COVID experts at the White House to partner in product work with YouTube. Google, in an internal email, noted that after a subsequent meeting with Flaherty, the White House staffer "particularly dug in on our decision making for borderline content" — which is content that doesn't cross Community Guidelines but rather brushes up against it, according to YouTube. A week later, Google acknowledged that it sent the White House the total amount of videos removed for COVID-19 vaccine misinformation, while discussing the government's desire for even more data. The next day, YouTube's Government Affairs team emailed YouTube's Product team, flagging the interactions with the White House.

An internal email from YouTube revealed a "high degree of interest" coming from the White House regarding vaccine misinformation and hesitancy.

"Unfortunately, the role of tech in addressing vaccine hesitancy is about to come under a massive spotlight, particularly as the supply of the vaccine is soon to outpace demand," the email continued. "The White House is very interested in our work on borderline content, and more specifically vaccine-related content as well as our work to promote authoritative sources for vaccines."

House Judiciary Chairman Jim Jordan (R-OH) told FOX Business that they knew the White House was working closely with Big Tech to censor the First Amendment and that "internal documents from Google obtained by the Judiciary Committee and Select Subcommittee show that their scheme extended to YouTube."

*******************************************************

Big Korean Study of Post-COVID-19 Vax Inflammatory Musculoskeletal Conditions

University researchers from Ewha Womans University College of Medicine, Mokdong Hospital and University Guro Hospital, both in Seoul, Korea conducted a retrospective nationwide cohort study tapping into data at the Korean National Health Insurance Service (NHIS) database. With a total of 2,218,715 patients from January 1, 2021, to 12 weeks post the second dose of vaccine for vaccinated persons and 12 weeks after September 30, 2021, for unvaccinated persons, the study team sought to investigate the incidence rates of inflammatory musculoskeletal disorders post COVID-19 vaccination, comparing to the unvaccinated cohort.

Among the two cohorts, the vaccinations included mRNA vaccine (Moderna/Pfizer-BioNTech), viral vector (AstraZeneca, J&J) and mixing and matching. Multivariate logistic regression analysis was used to determine the risk factors of musculoskeletal disorders after adjusting for potential confounders.

The authors report in their still-to-be-reviewed study paper that individuals who received any COVID-19 vaccine were more likely to be diagnosed with inflammatory musculoskeletal disorders than those who did not. The authors believe that the information will be useful in clarifying the adverse reactions to COVID-19 vaccines and informing people about their potential for inflammatory musculoskeletal disorders after vaccination.

The authors point out that earlier research on COVID-19 vaccines points to a range of adverse reactions related to proinflammatory actions that can lead to an excessive immune response and sustained inflammation. However, they claim no study has been conducted on the association between inflammatory musculoskeletal disorders and COVID-19 vaccines.

A strong study, the 2+ million individuals randomly selected from the Korean NHIS offers a substantial national cohort. Because Korea uses comprehensive medical databases for population-level analysis, overall, the reliability and representativeness bolsters these findings. The authors report that such large population-based databases, which are available only in Taiwan, Sweden, and Korea, offer “excellent resources for answering questions that are difficult to address using single-institution or small-scale studies.”

Conditions such as adhesive capsulitis, also known as frozen shoulder, an inflammatory condition characterized by shoulder stiffness, pain, and significant loss of passive range of motion, can debilitate individuals, interfering with work and quality of life. Long-term disability has been reported at 10-20% in patients, and the persistence of symptoms at 30-60%.

********************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs

***************************************************

Sunday, December 03, 2023


These Experts Advocated for Lockdowns; Now They Say They Were Wrong

As the dust settles from the COVID-19 pandemic and the fallout over lockdown policies becomes more pronounced, some lockdown proponents, like New York University Professor Scott Galloway, have admitted they were wrong for supporting lockdowns.

"I was on the board of my kid's school during COVID. I wanted a harsher lockdown policy. In retrospect, I was wrong," Mr. Galloway told Bill Maher.

"The damage to kids of keeping them out of school longer was greater than the risk. But here's the bottom line, myself, our great people at the CDC, I'd like to think the governor, we were all operating with imperfect information, and we were doing our best." he said, referring to the Centers for Disease Control and Prevention and then-New York Gov. Andrew Cuomo.

"Let's learn from it. Let's hold each other accountable, but let's bring a little bit of grace and forgiveness," he said.

Mr. Galloway isn't the only one to admit he was wrong for supporting lockdowns, especially for children.

However, some others aren't as quick to blame "imperfect information," and plead for forgiveness.

Dr. Ari Joffe, a clinical professor of pediatrics at the University of Alberta, Canada, and an attending physician in Pediatric Critical Care Medicine, initially supported lockdowns.

So did Kevin Bass, a seventh-year medical student and researcher at a Texas medical school.

Both now say they were wrong because of "groupthink" and "fear-mongering," rather than imperfect information.

And both push back against Mr. Galloway's notion that the powers that be were "doing [their] best."

On March 16, 2020, the Imperial College COVID-19 Response Team published modeling that showed without lockdowns enforced for more than two-thirds of the time over two years, "there would be 510,000 deaths in Great Britain and 2.2 million deaths in the United States by mid-April, surpassing ICU demand by 30 times," Dr. Joffe reported in his peer-reviewed paper, "COVID-19: Rethinking the Lockdown Groupthink."
The Imperial College estimated that there would be "7.0 billion infections and 40 million deaths" globally in the first year.

The result from that modeling was widespread fear, Dr. Joffe said, of which he was not immune.

Consequently, he fully supported government-imposed lockdown measures at the beginning of the pandemic because he believed "lockdowns would reduce viral transmission and deaths, as famously, inaccurately, and tautologically modeled at Imperial College," Dr. Joffe told The Epoch Times.

Mr. Bass, who said at the beginning of the pandemic he was a hard-core Covidian (someone who elevated COVID prevention and mitigation to an almost religious persuasion), said the Imperial College's modeling highly influenced his initial support for lockdowns, as did reports from the World Health Organization (WHO).

"They said it kills 3.4 percent of the people it infects—that was the World Health Organization's figure until early April—3.4 percent, that's way too many people! That's like one out of every 30 people is going to die," Mr. Bass told The Epoch Times.

"And then we had these Imperial College London models which modeled how many deaths there would be due to the pandemic in different scenarios, whether mitigated or unmitigated, with no lockdowns or measures taken.

"And there was essentially no other data. I think, because of the hysteria, the fear, the example of China perhaps, people had an excessive amount of confidence—scientists, social scientists—in the Imperial College of London models."

But as the pandemic unfolded, Dr. Joffe and Mr. Bass began to rethink their early lockdown support.

Recognizing Groupthink

"In the first few months of lockdown, I realized that my (and similarly trained medical colleagues) expertise was poorly suited to give advice during a pandemic," Dr. Joffe said.
He added that when he first saw the Imperial College's modeling, he failed to note that "the high-risk groups were those aged 70 years and older (especially in long-term care), and those aged 60 to 69 with severe comorbidities."

But that fact soon became apparent, and the infection fatality rate was more than 10 times lower than the reported case fatality rate.

"The modeling was flawed, and in general, modeling (forecasting) failed during the pandemic. This was because the models were based on flawed assumptions and non-transparent methods," Dr. Joffe said.

"If you put in inaccurate assumptions (e.g., the infection fatality rate was way too high; the population was modeled as homogeneous when in reality it is highly heterogeneous in terms of risk and exposure; the outbreak was modeled as never-ending exponential increase, unlike any epidemic in history; the herd immunity threshold was assumed to be far too high; and more), the model will show what you want it to show."

Dr. Joffe said that he also saw the effect of lockdowns on students at the university and came to recognize that his support of lockdowns was from a privileged position that "failed to recognize that loneliness, unemployment, and adverse childhood experiences are top risk factors for shortened lifespan, mental health problems, and chronic non-communicable diseases."

Plus, he'd "failed to recognize that missing school will affect an entire generation with reduced social development, executive function (i.e., decision-making ability), earning potential, and future lifespan, and lead to marked increases in adverse mental health outcomes."

Once he recognized those facts, Dr. Joffe began researching lockdowns and his paper was published on Feb. 26, 2021.

In his conclusion, Dr. Joffe states, "The economic recession, through austerity in government spending on the social determinants of health, can be expected to cause far more loss of life and wellbeing over the long-run than COVID-19 can.

"We must open up society to save many more lives than we can by attempting to avoid every case (or even most cases) of COVID-19. It is past time to take an effortful pause, calibrate our response to the true risk, make rational cost-benefit analyses of the trade-offs, and end the lockdown groupthink."

For Mr. Bass, the road to rethinking his lockdown support was more circuitous.

He said that in early 2022, he was trying to find new topics to discuss in health and, as a popular figure on social media, was becoming more skeptical of "things in general." Simultaneously, Mr. Bass realized his online audience was primarily peers, not the everyday person looking for health answers, so he decided to explore a "range of different issues."

"Even though I was very, very closely following the science, I was reading papers super closely, super carefully, and knew what I was talking about, I got a lot of pushback from the very same community that I had been a part of which used to cheer me on about debunking misinformation," Mr. Bass said.

"They started accusing me of misinformation! I started getting mobbed by my own team."

The pushback forced Mr. Bass to recognize the tribalism within his community and that they weren't following the facts but instead following conventional thinking and so-called experts with the most prominent online platforms.

"Once I realized that, I started to see it in many different things, and I started questioning," he said.

That questioning came to a head when, in 2022, Elon Musk bought Twitter, now X, and posted his pronouns as "Prosecute Fauci."

"I retweeted that, or maybe even heightened, quote-tweeted that, like approvingly, and I just got dogpiled," Mr. Bass said. "I was always a Covidian. I always thought that we should have lockdowns, we should have mask mandates, and vaccine mandates, and I was very authoritarian.

"Looking back on it now, it's embarrassing."

During that time, he was also listening to other luminaries who questioned the government response, and that gave rise to his own questions.

"They were saying things about COVID, and I thought, 'Well, that's very interesting. Maybe that's true. Maybe it's important for us also to keep an open mind about critical perspectives.' So, during this entire time, I was doubting and thinking about things," Mr. Bass said.

"And it became obvious that this whole zero-COVID narrative … was [expletive]. Like we weren't ever going to control COVID, and it just became obvious that lockdowns, in general, were a pipe dream, a fantasy. And to the extent that they could, you'd end up with a totalitarian nightmare."

Recognizing his error and wanting to acknowledge it, Mr. Bass posted to X on Dec. 12, 2022, "I was wrong about lockdowns and mandates. I was wrong and the reason I was wrong was my tribalism, my emotions, and my distorted understanding of human nature and of the virus. It doesn't matter much, but I wanted to apologize for being wrong."

Avoidable Mistakes

Dr. Joffe said, "governments put the wrong people in charge of advising and managing the public emergency of the pandemic.
"The public health medical officers were not trained nor experienced in managing a public emergency. The medical expert groups also were not trained nor experienced in managing a public emergency. All were susceptible to groupthink."

Dr. Joffe, along with David Redman, a retired lieutenant colonel at the Alberta Emergency Management Agency, said in a paper that emergency management agencies, with their specific procedures, should have managed the pandemic.

Instead governments controlled the response and focused only on things like "flattening the curve" and "protecting the healthcare system" and failed to calculate the impact that lockdowns would have on society against their true efficacy.

"A common mistake was to consider correlation as causation—meaning, when lockdowns were implemented, cases and hospitalizations sometimes decreased, and this was incorrectly interpreted as lockdown efficacy," Dr. Joffe said.

"The problem was, this was not due to causation … it was clear that regardless of lockdown, the trajectories of the pandemic were the same."

Mr. Bass agrees, "When the pandemic started, I was very aware of the downsides of this ideology, but still, I went along with it. My ultimate belief—and I think many people shared this—was that every human life is precious. I mean, nobody can argue with that, right?

"We thought, basically, 'Yes, we might have some economic devastation for a short period. Or yes, there might be some inconvenience,' as Fauci used to put it whenever he dealt with lockdown protesters or international leaders. But nonetheless, like these inconveniences, these slight mild economic recessions, they might not be all bad, and we'll rebound, was a thing we told ourselves. And so, we had this overwhelming focus on the positives."

More here:

********************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs

***************************************************

Friday, December 01, 2023



Pursuing justice’: Texas sues Pfizer for overstating COVID-19 vaccine effectiveness

Texas Attorney-General Ken Paxton has accused Pfizer of misrepresenting the effectiveness of the company’s COVID-19 vaccine in a lawsuit filed in state court.

The pharmaceutical giant used misleading statistics to promote its vaccine and sought to “intimidate and silence” those who questioned the product’s efficacy, the lawsuit, filed on Thursday Austin-time, alleges.

Paxton is seeking more than $US10 million ($15 million) in civil fines and a court order barring Pfizer from speaking publicly about the efficacy of its vaccine.

“We are pursuing justice for the people of Texas, many of whom were coerced by tyrannical vaccine mandates to take a defective product sold by lies,” Paxton said in a statement.

The lawsuit follows a probe launched by Paxton’s office in May into three major drug companies related to claims they made about the effectiveness of their vaccines. Paxton has been a vocal opponent of COVID-19 safety mandates since the onset of the pandemic.

In the complaint filed in a Lubbock County state court, Paxton said it was misleading for Pfizer to claim its vaccine was 95 per cent effective because it offered a “relative risk reduction” for people to who took it.

Paxton said the claim was based on only two months of clinical trial data, and claimed the pandemic got worse even after people started taking Pfizer’s vaccine.

“Pfizer intentionally misrepresented the efficacy of its COVID-19 vaccine and censored persons who threatened to disseminate the truth in order to facilitate fast adoption of the product and expand its commercial opportunity,” the complaint said.

Paxton’s statement included the claim: “COVID-19 cases increased after widespread vaccine administration, and some areas saw a greater percentage of deaths from COVID-19 among the vaccinated population than the unvaccinated.”

“When the failure of its product became apparent, Pfizer then pivoted to silencing truth-teller

**************************************************

Study suggests pandemic lockdowns accelerated ‘significant’ memory and cognitive decline in seniors

Follow America's fastest-growing news aggregator, Spreely News, and stay informed. You can find all of our articles plus information from your favorite Conservative voices.
A new study conducted by the University of Exeter Medical School, led by Dr. Anne Corbett, has revealed that the lockdowns and societal restrictions imposed during the pandemic had a detrimental impact not only on the mental health of children and teens, but also on elderly individuals.

Using data collected from 3,142 people aged 50 years or over who were taking part in a long-term dementia study in Britain, it was observed that there was a significant worsening of executive function and working memory among the cohort (average age 67.5) in both the first and second year of lockdowns.

Despite restrictions being eased after this period, it appears that much damage had already been done.

The study revealed that reduced exercise and increased drinking were significantly associated with cognitive decline among the entire cohort. Notably, depression was a prominent factor of cognitive decline among those who contracted COVID-19.

Additionally, it was found that loneliness had especially detrimental effects on those with mild cognitive impairment.

“People aged 50 years and older in the UK had accelerated decline in executive function and working memory during the first year of the COVID-19 pandemic, during which the UK was subjected to three societal lockdowns for a total period of 6 months,” said the study, published in the Lancet journal Healthy Longevity.

The British Government, funded by the National Institute for Health and Care Research, implemented restrictions on the number of times citizens could exercise outside during the pandemic, as well as closing gyms, golf courses, sports courts, swimming pools and indoor sports facilities.

“The scale of change is also of note, with all groups—the whole cohort and the individual subgroups—showing more than a 50% greater decline in working memory and executive function and many effect sizes reaching a clinically significant threshold of greater than 0·3,” said the researchers.

Governments across the West have implemented lockdown measures on and off throughout the pandemic, despite early indications that serious cognitive decline would be a consequence, especially for elderly individuals.

For example, Italian scientists noted in an October 2020 paper in Frontiers in Psychiatry that social disconnection – which is practically guaranteed by the closure of voluntary associations, churches, parishes, gyms and other meeting places for seniors – is a risk factor for dementia and likely to increase the risk of depression and anxiety amongst elderly people.

The researchers further highlighted that these factors mirror population-wide changes in health and lifestyle seen during and after lockdowns, prompting a pertinent question regarding the impact of the pandemic on cognitive health and risk across populations.

“Lockdown could affect disproportionately the mental health of old people, whom relatives contracted COVID-19, people who live alone and whose only social contacts take place outside home, and people who do not have close relatives or friends and rely on the support of voluntary services or social assistance,” said the paper.

*****************************************************

Half-Dose of COVID-19 Booster Just as Effective as a Full Dose: Study

Reducing the dose of a Pfizer COVID-19 booster vaccine can elicit a comparable immune response in adults compared to a full dose with fewer side effects, new research has found.

Led by the Murdoch Institute and the National Centre for Communicable Diseases in Mongolia, the study involved 601 participants over 18 years old from Mongolia, and is the first to assess and compare widely used COVID-19 vaccines in low- and middle-income countries.

The study focused on adults who had previously received AstraZeneca or Sinopharm COVID-19 shots, finding that a half dose of the Pfizer booster produced a non-inferior immune response.

Murdoch Institute’s Professor Kim Mulholland said reduced doses would make booster programs more cost-effective.

“Fractional dosing may improve COVID-19 booster acceptability and uptake and reduce the per-dose cost of COVID-19 booster programs,” he said.

“Policymakers and immunisation advisory committees can draw upon this data to make flexible boosting schedules decisions.”

However, the study noted that half-dose boosting may be less effective in adults primed with the Russian COVID-19 vaccine, Sputnik V.

Fewer Side Effects for Half Doses

Participants receiving half doses reported fewer side effects compared to those receiving full doses, highlighting the potential benefits of this approach.

Among half-dose boosted participants, 60 percent reported local reactions including pain and tenderness, and 25 percent reported systemic reactions including fevers, vomiting, diarrhoea, and headaches.

On the other hand, 72 percent of full-dose boosted participants reported local reactions, and 32 percent reported system reactions.

The study will continue to follow up on participants at six and 12-month intervals to explore their immune response, such as waning rates and breakthrough infections.

FDA Vaccine Adviser: Most Don't Need Yet Another COVID-19 Booster

This comes amid recommendations from the Food and Drug Administration's (FDA) vaccine adviser Dr. Paul Offit that most people did not need another COVID-19 booster.
In an article in a medical journal, he said that asking young, healthy people to get boosted with a variant-specific booster was pointless.

“I believe we should stop trying to prevent all symptomatic infections in healthy, young people by boosting them with vaccines containing mRNA from strains that might disappear a few months later,” Dr. Offit wrote in the paper.

Medical researcher and immunology specialist Kevin Bass echoed his sentiment saying people were likely to take a hard pass on the new COVID-19 booster shot unless it was mandated.

“Public opinion has swung so hard against the vaccines that I can’t imagine a scenario where a significant amount of people are going to sign up for another shot,” he told The Epoch Times in a recent interview. “If people have the choice, they are going to say no.”

Global Trial Investigating Reduced COVID-19 Boosters
The new research was published in the Lancet, and is part of an international clinical trial funded by the Coalition for Epidemic Preparedness Innovations (CEPI).

This trial, involving 3,300 healthy adults across Australia, Indonesia, and Mongolia, investigates the impact of administering a reduced dose of COVID-19 booster shots.

The efficacy, side effects, and acceptability of fractional doses explored will inform flexible booster strategies and address global vaccine supply challenges.

CEPI receives funding from the Australian government.

********************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs

***************************************************

Thursday, November 30, 2023



No proof face masks ever worked against Covid, claims UKHSA

There is no solid proof masks ever slowed the spread of Covid, England's former deputy chief medical officer said today.

Professor Dame Jenny Harries, who now heads up the UK Health Security Agency, said the evidence that coverings reduced transmission is 'uncertain' because it is difficult to separate their effect from other Covid curbs.

She also told the UK's Covid inquiry that government advice on how to make a mask using two pieces of cloth was 'ineffective'.

Studies showed at least three were needed for even a small effect on the spread of viruses, Dame Jenny said.

Meanwhile, she warned advice for the public to wear masks during the pandemic may even have given people a 'false sense of security' that they could reduce their risk of becoming infected if they wore one while mixing with others.

Dame Jenny wrote in her witness statement that the evidence base for using face masks in the community 'was, and still is to some degree, uncertain'.

She noted that the evidence for mask wearing varied depending on what materials it was made from. For example, a 'one or two layer cloth covering' is 'not particularly effective', she said.

And if someone doesn't wear it properly – fully covering the mouth and nose – 'it won't work', Dame Jenny added.

The inquiry was shown guidance on how people can make their own face masks from the first wave of the pandemic.

In response to the proposals in May 2020, Dame Jenny wrote that advice to use one or two pieces of fabric was 'ineffective'.

She told the inquiry that the evidence at the time said at least three layers were needed 'to give a positive impact' but even this finding 'was not very strong', so the advice was not effective.

Dame Jenny also warned that encouraging people to wear face masks led to a 'false sense of security' that people could mix more closely without risk.

Asked about a Government document recommending the use of face masks in May 2020, Dame Jenny said: 'We've got all sorts of safety issues here as well.

'One of the problems in May was when there were a lot of discussions about coming out of lockdown and opening up the economy and various other things – and the two metre, one metre (social distancing guidance).

'I think this was landing just about the same time as the "one metre plus" issue.

'The problem we had there was that there appeared to be a view permeating through, and a real concern and risk, that it was being conceived that if you did one metre and you wore a face covering slung round your cheek, or whatever it might be, that was fine.

'So, there was a risk that in encouraging face (masks) people would stop doing the thing that was really important, which was distancing and all the other things.'

Asked by inquiry chair Baroness Heather Hallett whether this led to a risk of a 'false sense of security', Dame Jenny replied: 'Yes, a false sense of security.

'But it was actually also overlapping with what was economically-driven policy, I think, to try and remove some of the distancing rules.'

She said, at the time, she and Professor Sir Jonathan Van Tam, England's former deputy chief medical officer, were 'really trying to highlight what we thought about the two metre and one metre rule discussions'.

Dame Jenny added: 'What was being conceived was if you wear a face covering and reduce everything to a metre, the face covering will make up for the difference, and the answer was no, it won't, and it definitely won't if it's ever not evidence based.'

Dame Jenny also revealed that she wrote to cabinet secretary Simon Case in May 2020, when he was No10 permeant secretary, expressing concern that people may believe they 'could go back to normal' wearing face coverings made from t-shirts, when there was no evidence base around the measure.

She told the inquiry: 'The first question was, shouldn't you be encouraging this? There's no harm'. 'The issue for me at that time, and I think Professor Van Tam shared it, was we definitely shouldn't be supporting something which was not evidence-based if it was going to promote a risk compensation.

'Of course, face coverings, as I know you'll be aware, is a wholly polarised debate and it's quite difficult to maintain a central position, if I'd said: "don't do any of this", somebody would have challenged back and said: "Well, surely there's no harm".

'My main concern was it would have been conceived as a safer way of moving about just when we got through the first tragic wave of a pandemic.'

Asked if she did anything about the concern, she added: 'Yes, well on the one metre, two metre (social distancing suggestion).

'I think this is very much around the same time that the CMO (chief medical officer), CSA (chief science adviser) and the two deputy CMOs wrote to Simon Case, because it was around lifting all the different industries and businesses and sectors at the same time.

'The anxiety was that if people just thought they could get a bit of t-shirt, put it around the face and that would solve all the problems and we could go back to normal, that was not going to be a good public health intervention.

****************************************************

What's the latest on COVID antiviral drugs, and who is eligible?

Australia is experiencing a fresh wave of COVID, seeing increasing cases, more hospitalisations and a greater number of prescriptions for COVID antivirals dispensed over recent months.

In the early days of the pandemic, the only medicines available were those that treated the symptoms of the virus. These included steroids and analgesics such as paracetamol and ibuprofen to treat pain and fever.

We now have two drugs called Paxlovid and Lagevrio that treat the virus itself.

But are these drugs effective against current variants? And who is eligible to receive them? Here's what to know about COVID antivirals as we navigate this eighth COVID wave.

What antivirals are available?

Paxlovid is a combination of two different drug molecules, nirmatrelvir and ritonavir. The nirmatrelvir works by blocking an enzyme called a protease that the virus needs to replicate. The ritonavir is included in the medicine to protect the nirmatrelvir, stopping the body from breaking it down.

Molnupiravir, marketed as Lagevrio, works by forcing errors into the RNA of SARS-CoV-2 (the virus that causes COVID) as it replicates. As these errors build up, the virus becomes less effective.

This year in Australia, the XBB COVID strains have dominated, and acquired a couple of key mutations. When COVID mutates into new variants, it doesn't affect the ability of either Paxlovid or Lagevrio to work because the parts of the virus that change from the mutations aren't those targeted by these two drugs.

This is different to the monoclonal antibody-based medicines that were developed against specific strains of the virus. These drugs are not thought to be effective for any variant of the virus from omicron XBB.1.5 onwards, which includes the current wave. This is because these drugs recognise certain proteins expressed on the surface of SARS-CoV-2, which have changed over time.

What does the evidence say?
As Lagevrio and Paxlovid are relatively new medicines, we're still learning how well they work and which patients should use them.

The latest evidence suggests Paxlovid decreases the risk of hospitalisation if taken early by those at highest risk of severe disease.

Results from a previous trial suggested Lagevrio might reduce COVID deaths. But a more recent, larger trial indicated Lagevrio doesn't significantly reduce hospitalisations or deaths from the virus.

Australia is riding another COVID wave — and the most vulnerable are the least vaccinated
As a new wave of COVID-19 hits Australia, why are so few aged care residents up-to-date with their COVID-19 vaccinations?

However, few people at highest risk from COVID were included in this trial. So it could offer some benefit for patients in this group.

In Australia, Lagevrio is not routinely recommended and Paxlovid is preferred. However, not all patients can take Paxlovid. For example, people with medical conditions such as severe kidney or liver impairment shouldn't take it because these issues can affect how well the body metabolises the medication, which increases the risk of side effects.

Paxlovid also can't be taken alongside some other medications such as those for certain heart conditions, mental health conditions and cancers. For high-risk patients in these cases, Lagevrio can be considered.

Some people who take COVID antivirals will experience side effects. Mostly these are not serious and will go away with time.

Both Paxlovid and Lagevrio can cause diarrhoea, nausea and dizziness. Paxlovid can also cause side effects including muscle aches and weakness, changes in taste, loss of appetite and abdominal pain. If you experience any of these, you should contact your doctor.

More serious side effects of both medicines are allergic reactions, such as shortness of breath, swelling of the face, lips or tongue and a severe rash, itching or hives. If you experience any of these, call 000 immediately or go straight to the nearest emergency department.

Be prepared

Most people will be able to manage COVID safely at home without needing antivirals. However, those at higher risk of severe COVID and therefore eligible for antivirals should seek them. This includes people aged 70 or older, people aged 50 or older or Aboriginal people aged 30 or older with one additional risk factor for severe illness, and people 18 or older who are immunocompromised.

A COVID infection now could spell trouble in three decades
Genes, environment and lifestyle are some of the risk factors for serious diseases like Parkinson's and Alzheimer's. This is why scientists believe COVID-19 infection should be added to the list.

If you are in any of these groups, it's important you plan ahead. Speak to your health-care team now so you know what to do if you get COVID symptoms.

If needed, this will ensure you can start treatment as soon as possible. It's important antivirals are started within five days of symptom onset.

If you're a high-risk patient and you test positive, contact your doctor straight away. If you are eligible for antivirals, your doctor will organise a prescription (either an electronic or paper script).

These medicines are available under the Pharmaceutical Benefits Scheme (PBS) and subsidised for people with a Medicare card. The cost for each course is the standard PBS co-payment amount: $30 for general patients and $7.30 for people with a concession card.

So you can rest and reduce the risk of spreading the virus to others, ask your pharmacy to deliver the medication to your home, or ask someone to collect it for you.

********************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs

***************************************************

Wednesday, November 29, 2023


New COVID Variant Spreading in US, Experts Explain Risks
Compared to Eris, BA.2.86 has a significantly lower growth efficiency, meaning that it is less capable of replicating itself in the human bodies.


The new BA.2.86 variant, unofficially known as Pirola is taking hold in the United States.

Between Oct. 28 to Nov. 25, its prevalence increased from 1 to around 9 percent in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC).

The World Health Organization designated Pirola as a variant of interest on Nov. 21, yet it also found the public health risk posed by BA.2.86 to be “low at the global level (pdf).”
In an update published on Nov. 27, the CDC agreed with the WHO’s assessment “that the public health risk posed by this variant is low compared with other circulating variants, based on available limited evidence.”

Current Research Suggests Low Risk of Disease

Pirola is derived from BA.2, an earlier Omicron variant.
Other variants derived from BA.2 include XBB.1.5 which became the dominant strain in early 2023.

The current dominant variant is H.V.1, and it is derived from the variant EG.5, unofficially known as Eris, a previously dominant variant in the United States.

“At this time, BA.2.86 does not appear to be driving increases in infections or hospitalizations in the United States,” the CDC wrote.

Research outside of the United States similarly suggests that Pirola should not be more severe than current variants.

Researcher Yunlong Cao, who holds a doctorate in physical biochemistry from Harvard found that Pirola “exhibits lower cell infectivity” compared to XBB.1.5 and Eris.

A preprint study from Japan found that while Pirola may be more transmissible than Eris a previous dominant variant, it is less likely to cause disease.

Compared to Eris, Pirola has a significantly lower growth efficiency, meaning that it is less capable of replicating itself in the host, the authors wrote.

“This is not the second coming of omicron. If it were, it is safe to say we would know by now,” Bill Hanage, associate director and professor of epidemiology at Harvard wrote on X on Sep. 1 ,when the variant's prevalence was significantly lower.

Prior Infections Gives Immunity Against the New Variant

Compared to BA.2, its ancestral subvariant, Pirola has more than 30 mutations in its spike protein. The virus uses the spike protein to infect human cells.

The substantial number of mutations initially raised concerns among virologists, who feared this variant might partially evade earlier immunity from previous exposure, whether from natural infection or prior vaccination.

However, evidence is still lacking to predict if there will be more immune evasions as well as the severity of future Pirola cases.

Mr. Cao’s own research in mice who have been vaccinated or infected with XBB vaccines showed that the antibodies generated “cannot well recognize and neutralize BA.2.86,” he wrote in a thread posted on the social media platform, X.

However, Pirola had a low cell infectivity, which can affect the variant's transmission, he added.

In discussion of Mr. Cao’s findings, Mr. Hanage agreed that immune evasion is not a definite indication of more severe infection and transmission.

“Any hopeful virus has to have some immune evasion, because almost everyone has immunity,” he wrote.

The most recent research on Pirola's immune evasion abilities comes from a series of reports conducted by researchers at Columbia University.

The first study, published in Nature, tested Pirola, XBB1.5, and Eris spike proteins against antibodies produced from a breakthrough XBB infection.

These antibodies conferred robust neutralizing activity against Pirola. The authors also noted that Pirola's ability to evade immunity was no better than that of XBB1.5 and EG.5.

The same group of researchers then tested antibodies produced from the new XBB1.5 COVID vaccine against several variants, including XBB1.5, Eris, and JN.1, a derivative of Pirola. The findings were published in a preprint.

The authors found that, compared to all variants investigated, JN.1 was the most immune evasive against antibodies produced from the vaccine.

HV.1: The Current Dominant Variant

The current dominant subvariant is HV.1, a new variant derived from Eris. Eris is currently the most dominant globally and HV.1 succeeded Eris as the dominating variant in the U.S. on Oct. 28.

Like Pirola, the WHO has classified HV.1 as a variant with low public health risk. The variant accounted for about 31.5 percent of all cases in the United States as of Nov. 25.

*************************************************

Is It Possible that COVID-19 Boosters Trigger a Cancer Relapse?

COVID-19 boosters are used to activate the immune response by synthesizing antibodies against foreign pathogens, however, some adverse events have been associated with these boosters. In the aggregate via published case series alone, over two hundred cases of cancer or cancer relapse have been reported yesterday by TrialSite. Yet none of these cases can prove causation (the studies aren’t designed for that), and the incidence remain rare given over 230 million people are considered fully vaccinated in America alone. Regardless, several cases of cancer relapse have been reported after the administration of COVID-19 boosters, according to Angus Dalgleish, a professor of oncology at St.George’s University of London. During an interview, he raised his concerns about the COVID-19 boosters’ long-term consequences, perturbation of the immune system, and the development or relapse of aggressive cancers. TrialSite investigates the reports of cancer related to COVID-19 vaccination.

Dr. John Campbell, a retired British nurse and healthcare educator, interviewed Professor Dalgleish to discuss his insights into boosters, immunity, and cancer risk. The focus of Dalgleish’s extensive research is immunotherapies and cancer vaccines. In this interview, he described his observations on patients suffering from melanoma.

Melanoma is a type of skin cancer that forms in the skin cells called melanocytes. These cells produce melanin which gives color to the skin. The exact cause of melanomas is still unclear, but it is widely accepted that exposure to ultraviolet radiation from sunlight is the reason for the rapid rise in melanoma cases worldwide. It is easy to treat it if it gets detected at an early stage.

Dalgleish’s observations on melanoma patients

Dalgleish observed cancer patients’ response to immunotherapies (use of the body’s own defense system to fight against diseases) and realized that vitamin D deficiency is associated with melanoma. Moreover, he added that improving the body’s vitamin D status can enhance immunotherapy outcomes.

Several studies support Dalgleish’s claim that vitamin D deficiency is associated with melanoma. A retrospective cohort study in 2022 found that vitamin D deficiency is responsible for worsening the overall survival of melanoma patients. Yet observational studies such as the latter cannot necessarily establish causation.

Additionally, an experimental study suggested that vitamin D deficiency is associated with thicker melanoma tumors, which can cause poor prognosis at the time of diagnosis.

Dalgleish also noted that melanoma patients often return with a cancer relapse even after 20 years. By observing their medical history, he noticed that these patients had experienced stress like divorce, bereavement, or bankruptcy, which caused immune suppression for a significant period. He also realized that there was another factor that increased the relapse rate – receiving a COVID-19 booster shot.

According to Prof. Dalgleish, these boosters are meant to enhance the immune response, but the relapse of cancer raises questions about their effect on immune response.

The mechanism behind the increased relapse

Dalgleish suggests the vaccines mostly deal with antibodies while laying more emphasis on the importance of innate immune response by activating T-cells. These cells effectively remove cancer cells and viral-infected cells. Also, these act during the time when the effective adaptive immune response (antibody production) is in the process of developing. T-cell activity reduces with age, particularly after age 55, which increases the incidence rate of cancer in elderly people.

The boosters do not cause the body to make IgG1 and IgG3, which are neutralizing antibodies, instead, they switch to IgG4 antibodies which are less effective in combating infection or disease. These IgG4 antibodies suppress the T-cell response which causes a suppression in the fast-acting innate immune response. This, according to the hypothesis, increases the chance of cancer relapse in people after getting COVID-19 boosters. But this would need to be fully investigated for any affirmative declarations, would it not?

Immune system perturbation linked to cancer

Dalgleish mentioned that there are many unnecessary antibodies formed inside the body following COVID-19 boosters. He called this “antibody-dependent enhancement.”

Antibody-dependent enhancement refers to a situation in which antibodies emerge during an immune response but do not prevent an infection. Instead, these antibodies actually help the virus penetrate the cells. Thus, Dalgleish claimed that boosters do not provide protection instead, they perturb the immune system and cause more aggressive forms of cancer. He gave an example case of lymphoma diagnosis in one of his colleagues after vaccination.

The London-based oncologist implies of the possibility of emerging cancers such as B-cell leukemia and renal cancers in the near future due to immune system perturbation induced by vaccines. Again this would need to be formally studied, as the observations of one physician or even a handful doesn’t equate to evidence.

Potential impacts of mRNA vaccines on the immune system

In the interview, Dalgleish also talked about mRNA vaccines. He expressed his frustration over the use of the SV40 promoter in mRNA vaccines and explained that it is an oncogenic promoter used for developing cancer in mice.

The oncologist suggests questions about the composition and potential risks of mRNA vaccines. He also extended his concern to the integration of DNA. TrialSite previously published an article analyzing these claims of DNA contamination in Pfizer and Moderna mRNA-based COVID-19 vaccines. While numerous activists critical of the COVID-19 vaccines have pounced on “plasmidgate,” TrialSite has been clear that some of the studies are questionable—such as the German study where most of the vaccine vials were opened upon arrival at the third-party lab doing the testing.

Given the testimony of Professor Philip Buckhaults in front of the South Carolina Senate on the matter TrialSite has suggested formal, government, and industry investigations.

TrialSite’s founder Daniel O’Connor, an expert in Food and Drug Administration (FDA) regulated clinical research process and technologies, was in touch with leadership at the regulatory agency who committed to passing along the information. But the TrialSite publisher told this writer, “The regulators don’t seem too concerned at all about the reports of DNA snippets in the vaccine samples.”

What about the Spike Protein?

There are claims that the spike protein, which was held responsible for vaccine injuries, remained at the injection site and did not integrate. The formal narrative has it that the spike protein flushes from the lymphatic system within a week or so but enough published material has emerged to refute that oversimplified claim.

Dalgleish challenges the premise powering claims for a lack of spike integration.

To examine these claims, autopsies need to be done but Dalgleish points to the difficulty of doing autopsies on patients who had died after vaccination. He said that it had been overruled despite obtaining relatives’ consent for post-mortems. This caused a lack of transparency.

Censorship and media influence also represent formidable issues because the government discouraged criticism of vaccines argues the oncologist. This hinders open discussions about vaccine safety and effectiveness.

********************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs

***************************************************

Tuesday, November 28, 2023


Covid-19 cover-up exposed – at last

SHARRI MARKSON

It’s astonishing to consider that Anthony Fauci stood on the White House podium in early 2020, beside the president of the United States, and resolutely told the world that Covid-19 was a natural virus.

Curiously, he failed to mention that his agency had funded coronavirus experiments in Wuhan so dangerous that they had been banned in the US by the Obama administration. Fauci knew, too, that eminent scientists privately harboured concerns Covid-19’s genetic sequence had unusual features inconsistent with evolutionary theory.

Yet he reassured the public that there was no reason to suspect a laboratory incident in Wuhan and, as he did so, Fauci cited as evidence a new scientific paper.

Far from being a conclusive, rigorous scientific study, it was, in fact, a piece of commentary that had been rejected from a prestigious medical journal.

This is not to blame Fauci for the pandemic, although his agency may have funded the research which created Covid-19.

The culpability truly lies in Wuhan where scientists were pushing the boundaries of acceptable experimentation on coronaviruses to make them more infectious and transmissible to humans.

For years the scientists at the Wuhan Institute of Virology had been playing God, and had grown increasingly bold and, as it turns out, shockingly careless, conducing their almost existential experiments in low-security laboratories.

But Fauci’s role in claiming the virus was natural, when he had no incontrovertible evidence to make such a claim, goes to the very heart of the cover-up over the origins of Covid-19. Instead of advancing the world’s understanding of what was unfolding, he was deliberately covering it up and, in doing so, ­creating confusion that crippled the world for years.

He also led desperate and diabolic anti-scientific efforts to shut down investigation into the origins of Covid-19; so anxious was he to divert attention from a lab leak and what would surely follow – accountability of him and his agency.

The early insistence of zoonosis from a such an esteemed and trusted figure saw the lab leak theory assigned to the conspiracy pile, censored by tech giants and ridiculed by the media.

Unravelling the web of cover-ups, conflicts of interest and false narratives surrounding the origins of Covid-19 has been a large part of my life over the past 3½ years.

I’ve written an investigative book, created a documentary and a podcast and written dozens and dozens of newspaper articles, features and television reports.

I’ve interviewed hundreds of scientists, government officials, investigators, intelligence agency insiders and whistleblowers from all over the world. They each share a common determination; to discover the truth of the origins of Covid-19.

Piecing together information from these individuals has helped to form a more complete picture of what we know about how the first pandemic in 100 years began.

As we near the fourth anniversary since Covid shook the world, there’s a new chapter in this investigation – a documentary airing on Tuesday night on Sky News called What Really Happened in Wuhan, the Next Chapter.

For the first time, Fauci’s boss, the former assistant secretary for preparedness and response, Dr Robert Kadlec, fronts the cameras to divulge their confidential conversations where they decided it would be best if they downplayed the possibility of a lab leak.

Ostensibly, this was to encourage co-operation from China, but Kadlec believes Fauci had reason to protect his own reputation and that of his institute which had funded research in Wuhan.

Haunted by the downstream effects of the decision they made to divert attention away from accusations of a lab leak, Kadlec says he still lies awake at night, reflecting on what they did.

So eager were scientists to shield China from any suggestion its scientific research had started the pandemic, and to protect their own research from being subject to new regulations, there was complicity among international scientists in downplaying or rejecting the lab leak theory.

As a result, there have been no moves to regulate or ban gain-of-function experiments on coronaviruses or other pathogens with pandemic potential globally.

Yet scientists from the four groups within the US intelligence community that engage in scientific analysis all concur that SARS-CoV-2 was most likely ­genetically engineered.

In our new documentary, Kadlec warns that another pandemic could easily eventuate because the lessons haven’t been learned from Covid-19.

For all the excessive government intervention during the pandemic, the most fundamental step of having a conversation about whether scientists should stop dangerous experiments on coronaviruses hasn’t taken place.

It’s also incomprehensible that an event that killed seven million globally would not be deemed significant enough for our world leaders to raise at a diplomatic level with China.

It’s bewildering that there has been no serious investigation into the origins of Covid-19.

It speaks to the lack of courage and political conviction of our world leaders that it’s been left to congressional subcommittees, journalists and internet sleuths to investigate the most consequential period of our lifetimes.

And so, this latest Sky News documentary on Tuesday night plays a role in moving the public debate on this topic forward, providing fresh information about the scientific research that may have started the outbreak in Wuhan, and airing more staggering claims of how public debate was silenced at the highest levels.

**************************************************

Government Deceit

John Stossel

“Experts” were confident that they knew what America should do about COVID-19. They were wrong about so much.

Officials pushed masks, including useless cloth ones. Dr. Anthony Fauci said, “Don’t wear masks”—then, “Do wear them.”

Some states closed playgrounds and banned motorboats and Jet Skis. Towns in New York banned using leaf-blowers. California pointlessly closed beaches and gave people citations for “watching the sunset.” The list goes on.

Sen. Rand Paul’s new book, “Deception,” argues that government experts didn’t just make mistakes; they were purposely deceitful. A few weeks ago, this column reported how Paul, R-Ky., was correct in accusing Fauci of funding virus research in Wuhan and lying about it.

In my new video, we cover other government deceit.

Paul says, “There’s been one set of truths in private and another set of truths for the people who aren’t smart enough to make their decisions.”

He points out that Fauci, in private, told fellow bureaucrats that masking is pointless. Fauci wrote in one email: “The typical mask you buy in the drug store is not really effective in keeping out virus, which is small enough to pass through the material.”

But in public, complains Paul, Fauci would sometimes wear multiple masks.

“Things that have no scientific basis in fact. … There’s two sets of information going out, one privately and one publicly.”

“Why?” I ask.

“They think that there could be hysteria. They’re in government. They need to do something. … So let’s get everybody occupied with wearing masks. … But in the end, the Cochrane analysis looked at 78 randomized studies and found that masks didn’t work at all.”

“N95 masks may work,” I say.

“The Cochrane analysis looked at the N95 and found they didn’t work very well,” Paul replies.

Another mistake: The virus is 500 times more likely to kill people ages 65 and up than kill kids. But our government told parents: Mask your children. Some states kept kids out of schools for two years.

Also, “When they approved the third vaccine for children,” says Paul, “the first committee was the [Food and Drug Administration] committee. … They came out with the advice: 65 and older. Nobody else. The [Centers for Disease Control and Prevention] had another vaccine committee. … They said the same thing … [but] Rochelle Walensky, a political appointee of [President Joe] Biden, overrode both scientific committees and said the vaccine booster should be given to six months and up.”

“Why? What’s the motivation?” I ask. “Get more people frightened, and then they’ll take the vaccine and that will save America?”

Paul says, “I think most of them are not very smart and they just blindly think, ‘Take the damn vaccine, shut up and take it. It’s good for you.’”

Has he been vaccinated?

“God gave me my vaccine.” He tells me. “I was naturally inoculated. But members of my family, my wife, got vaccinated. We’re not against the advice.”

I clarify, “‘Naturally inoculated,’ meaning you got COVID?”

“I had COVID, so I have immunity,” he replies.

At the start of the pandemic, Sweden’s health officials did not shut down restaurants or other businesses. They also announced that they would not close schools for younger children.

For doing that, Sweden was repeatedly trashed by American government officials and the media. Time magazine called Sweden’s plan “a disaster.”

But the Swedish approach was right! Not only did Sweden escape the economic and social harm of lockdowns, but its COVID-19-related death rate was lower than that of most other countries.

“It turns out they did as well, or better, than most parts of Europe,” says Paul.

“Better,” I point out.

“They also didn’t mandate masks in schools [or] close the schools. Everything we did in this country was wrong.”

I push back. “On balance, vaccines were a good thing. They work for older people, people my age.” In fact, Republican anti-vax “messaging may have killed people!” Before the vaccine came out, an equal number of Republicans and Democrats died. But once the anti-vax messages spread, Republicans had a higher death rate.

Paul replies, “Vaccine hesitancy comes from people’s disbelief in government.”

He adds, “I think people learned from this … [learned] what to trust and what not to trust. People will be smarter the next time around.”

https://www.dailysignal.com/2023/11/15/government-deceit/ ?

********************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs

***************************************************

Monday, November 27, 2023



Interesting Swedish study

Lots of vaccinated people got Covid but vaccination did tend to protect them from long Covid

A large, population-based cohort study-- part of the project SCIFI-PEARL, a nationwide linked multi-register, observational study of the COVID-19 pandemic in Sweden—was organized to investigate the effectiveness of primary COVID-19 vaccination, defined as the first two doses plus the first booster dose (3 doses) within the recommended schedule targeting post-COVID condition (PCC) another term for long COVID. The study included all Swedish adults aged 18 years and up with COVID-19 first registered between December 27, 2020, and February 9, 2022, totaling 589,722 persons across the Scandinavian nation’s two largest regions. Capitalizing on a health system with rich data collection and management, the study team monitored the study participant data from one of the following data points whichever came first: COVID-19 infection until death, emigration, vaccination, reinfection, a PCC diagnosis—based on ICD-10 diagnosis code U09.9, or end of follow-up period which was November 30, 2022. In the study, persons receiving at least one dose of COVID-19 vaccine prior to infection were deemed vaccinated. The study authors represented by corresponding author Maria Bygdell, a research fellow and Doctor of Medicine with the University of Gothenburg, and colleagues established a primary endpoint of PCC (long COVID) clinical diagnosis, while the team employed use of Cox regressions adjusted for age, sex, comorbidities (e.g. diabetes, cardiovascular, etc.), number of healthcare contacts during 2019 and other socioeconomic factors plus virus variant prevalent at time of infection for the study. While this observational study cannot prove causation, and the study has some glaring limitations (don’t factor in reinfection) the outcomes demonstrate a robust association between COVID-19 vaccination prior to infection and lower risk of PCC (long COVID) diagnosis.

**********************************************

Excess mortality and Covid vaccination: is there a correlation?

Since the introduction of Covid vaccines, the official narrative in Australia (and other parts of the world) is that these vaccines are safe, efficacious, and working well. However, this claim is considered to be untrue, as demonstrated by both the science and the statistics.

There is compelling evidence that the official narrative promoted by politicians and health bureaucracies, and enforced by politicised police forces, is misleading and even irresponsible in the light of the demonstrable side-effects of mRNA vaccines.

The Australian government effectively treated any reasonable concern about the safety of Covid vaccines as a form of domestic terrorism. From 2017 to 2022, the Department of Home Affairs petitioned social media sites to censor information about these matters no less than 13,646 times. This included suppressed Covid posts from doctors who disagreed with, or even questioned, official public health and vaccine information.

Especially egregious was the admonishment and de-registration of Australian medical doctors who attempted to provide vaccine exemptions or prescribe alternative medicine to alleviate or prevent Covid. ‘The conclusion taken from the collective authoritarian decisions is that medical choice is no longer a prerogative of the doctor-patient relationship in Australia,’ said Robert Clancy AM, a clinical immunologist and emeritus professor of medicine.

We now know that mRNA vaccines prevent neither infection nor transmission of the Covid virus. For example, a recent study by Cleveland clinic researchers concluded that people who received two or more doses of the vaccine were more likely to get infected with Covid. They found that, among 48,344 working-aged clinic employees, those not ‘up-to-date’ on vaccination had a lower risk of Covid than those ‘up-to-date’.

‘If a vaccine fails to stop disease transmission, then the idea that you need to vaccinate other people so that I’m protected is just false,’ said Dr Jayanta Bhattacharya, a professor of medicine and health research and policy at Stanford University.

To make it worse, a comprehensive comparative research analysis has found that Covid vaccines are directly associated with the disturbing rise in the mortality rate among countries of the Southern Hemisphere.

Denis Rancourt is a former professor of physics at the University of Ottawa. Maurine Baudin has a PhD in microbiology from the Université Paris Sud (Paris XI). Joseph Hickey is a data research scientist with a PhD in Physics. Jérémie Mercier is a chemist and health educator with a PhD in environmental research. Together these researchers have recently produced an empirical research paper entitled Covid vaccine-associated mortality in the Southern Hemisphere.

17 countries were studied by these researchers: Argentina, Australia, Bolivia, Brazil, Chile, Colombia, Ecuador, Malaysia, New Zealand, Paraguay, Peru, Philippines, Singapore, South Africa, Suriname, Thailand, and Uruguay). Together these countries comprise 9.10 per cent of worldwide population and 10.3 per cent of worldwide Covid vaccinations (vaccination rate of 1.91 injections per persons, all ages) through virtually every vaccine type and manufacturer.

According to these researchers, ‘All-cause mortality by time is the most reliable date for detecting and epidemiologically characterising events causing death, and for gauging the population-level impact of any surge or collapse in deaths from any cause.’ In these 17 countries, they found no evidence of any beneficial effect of Covid vaccination on all-cause mortality, nor any proportional reduction in the mortality rate. On the contrary, the opposite is true.

In that research paper, the authors also showed that every country with sufficient mortality data (Australia, Bolivia, Brazil, Chile, Colombia, Ecuador, Malaysia, New Zealand, Paraguay, Peru, Philippines, Singapore, South Africa, Thailand, and Uruguay) invariably exhibited an unprecedented and relatively sharp peak or surge in all-ages deaths during or after January-February 2022, which was synchronous with or immediately preceded by a rapid rollout of a Covid vaccine booster, dose 3 or 4, depending on the country.

Regarding the evidence provided in support of causality and toxicity, the authors of this research paper include examples where no detectable excess mortality occurred until the vaccines were rolled out, thus concluding that ‘it is well-established that Covid vaccine injections have caused and are likely to cause the deaths of individuals’. These researchers, in their own words:

‘…have found no evidence in [their] extensive research on ACM [All-deaths Cause Mortality] that Covid vaccines had any beneficial effect. If vaccines prevented transmission, infection or serious illness, then there should have been decreases in mortality following vaccine rollouts, not increases which were observed in every elderly group subject to rapid booster rollouts. And, mortality would not have increased solely when vaccines were rolled out, where no excess mortality occurred prior to vaccine rollouts, as we have documented in 9 countries across 3 continents.’

These researchers previously reported several instances in which anomalous peaks in all-cause mortality appear to be associated with rapid Covid vaccine-dose rollouts, as well as instances where the start of the vaccination campaign coincided with a new period of sustained elevated mortality. These are countries in which, for approximately one year after the WHO’s 11 March 2020 declaration of a pandemic, ‘there were no net extra deaths that could be attributed to a pandemic or to pandemic-response medical or government measures’.

Since the excess mortality in these countries occurred only after vaccine rollouts, the authors conclude that these vaccines certainly did not reduce serious illness (as claimed by manufacturers) enough to reduce any risk of death. On the contrary, according to them, there is strong evidence for a causal correlation between rapid first-doses and booster rollouts and immediate peaks in all-cause mortality, including peaks of mortality in seasonal cycles when peaks never occur. These findings appear to be conclusive and indicate that such vaccines lead to the deaths of individuals, which the researchers then remind us has already been demonstrated by:

Many detailed autopsy studies (reference provided)

Adverse effect monitoring (reference provided)

Studies of vaccine-induced pathologies (reference provided)

An established causal link to vaccine-induced pathology, by histopathology and immunohistochemical staining of skin biopsy specimens (reference provided)

Secondary analysis of serious adverse events reported in placebo-controlled, industry phase III randomised clinical trials (reference provided)

More than 1,250 peer-reviewed publications about Covid vaccine adverse effects (reference provided)

The known vaccine injury compensation programs of states worldwide, which include death resulting from the Covid vaccines (reference provided)

All 17 countries in their comparative research analysis had transition regimes of high all-cause mortality after the vaccines were deployed and administered. Accordingly, unprecedented peaks occurred precisely in January-February of 2022, which are synchronous with rapid booster-dose rollouts of Covid vaccination. The clearest example provided is the sharp all-cause mortality peak occurring in January-February 2022 in Australia, which is concomitant with the rapid rollout of dose 3 of the vaccine in the country.

Like Australia, countries such as Chile and Peru had a sharp all-cause death peak occurring over that same period, which is concomitant with the rapid rollout of Chile’s dose 4 and Peru’s dose 3 of the vaccine. In fact, the authors found the same phenomenon everywhere that data was available, thus making these findings rather conclusive. ‘There can be little doubt that the mass Covid vaccination campaigns caused the temporally associated excess mortality in the 17 countries of the present study, and in other countries studied to date.’ Accordingly, ‘There occurs an onset or increase of a large excess ACM on rolling out the Covid vaccines, in every country and state or province, studied to date, on virtually all continents, including for initial rollouts…’

Rancourt et al are therefore satisfied that the information available extensively demonstrates that Covid vaccines can cause death and that they did not save lives. On the contrary, these vaccines appear to be lethal toxic agents ‘with a high degree of certainty’. This leads the authors to state that adverse-effect monitoring, clinical trial reports, and death-certificate statistics have greatly underestimated the fatal toxicity of Covid vaccines.

These concerns are too serious to ignore. The suspicion that some people have been misled about the safety and efficacy of these vaccines has been further strengthened by the empirical data. The potential for severe injury by these vaccines is a matter that deserves more serious reflection. None were more instrumental in causing this tragedy than the Australian government and their loyal mouthpieces in the media. According to Professor Clancy,

‘The media has a concerning role in the propagation of misinformation, preferring to support an ideologic narrative, rather than to engage in responsible journalism. Misinformation driven by pharmaceutical companies to protect their vaccines, and strongly reinforced by academic, government and health authorities, leads to many unnecessary hospital admissions and deaths’.

So, the question is: Have the Australian governments and the mainstream media colluded in order to ensure an increase in Big Pharma’s corporate profits, which however, does not prioritise the protection of public health?

Be that as it may, it is increasingly difficult to hide the fact that people have died from these vaccines. The tragic consequences of mandatory vaccination are now all too visible in our society.

Above all, we are convinced that it is important to open up this type of conversation, lift the media suppression, and eliminate the muzzling and penalties imposed on those with alternate views or with a desire to promote further discussion. Then society will have to work out the issues of blame and penalties.

********************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs

***************************************************